Skip to content

Treace Medical Concepts, Inc.

TMCI

CIK 0001630627

← back to feed
Revenue (TTM)
$197.37M
+1.6% YoY Q1 Apr 2026
Net Income (TTM)
−$67.57M
−5.8% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$1.07
−3.3% YoY Q1 Apr 2026
Gross Margin
79.4%
Q1 Apr 2026
Operating Margin
-33.1%
Q1 Apr 2026
Net Margin
-34.2%
Q1 Apr 2026
Free Cash Flow (TTM)
−$25.05M
Q1 Apr 2026
Cash
$9.54M
Q1 Apr 2026
Total Debt
$57.6M
Q1 Apr 2026
Shares Outstanding
64.87M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings